November 21, 2026

Medical biotech centre opens in Dhaka

The government eyes using this sophisticated technology in the healthcare services.

bdnews24.com News Service

bdnews24.com

Published : 05 Aug 2012, 04:35 PM

Updated : 09 Aug 2022, 04:05 PM

Dhaka, Aug 5 (bdnews24.com)—The Health Minister on Sunday inaugurated the Centre for Medical Biotechnology in Dhaka as the government eyes using this sophisticated technology in the healthcare services. Based on the National Guidelines on Medical Biotechnology 2010, the Centre has opened to facilitate different medical institutes initially in the advanced diagnostic tests and researches. "This is just the beginning," A F M Ruhal Haque said while inaugurating the Centre at Institute of Public Health building. "It (biotech) has massive potential in the health sector," he said, "we have been able to achieve food autarky due to the use of biotechnology in agriculture." He suggested that the authorities collaborate with international centres for strengthening the Centre. Programme Manager of the Centre Dr Ashish Kumar Saha said they had already surveyed the availability of resources in different institutes to carry out biotech activities in Bangladesh. Line Director of the Management and Information System Prof Abul Kalam Azad highlighted the use of biotechnology in medical science. "Particularly drug industries can be benefited," he said, "in a traditional system, marketing a new drug requires 10-12 years, needs volunteers for trial and have risk of adverse effects during the trial." "A biotech drug can be even cheaper," he said, "in the US, seven best-selling drugs out of 20 are biotech drugs." He said Bangladesh could earn huge money only by selling stem cells collected from the umbilical cords of a newborn. Using bioinformatics, he said it can be predicted even 10 years before an antibiotic becomes resistant. "We can find out exactly what causes the disease by biotechnology." One application of biotechnology is the production of vitamin-A enriched transgenic variety of rice, Golden Rice. The rice was produced with genes for the synthesis of beta-carotene taken from the daffodil plants and inserted into the genome of a strain of rice, using Agrobacterium as the vector, to effect the transfer. But, he suggested, awareness about the biotech. "There are immense possibilities of biotechnology, but we don't know about the future whether there will be environmental hazards after 20 years or 50 years." "But we have to accept it even if we want to avert the hazard," he said. He, however, said 'we have to be careful about the patency of a biotech product'. Citing instances, he said at least 16 varieties of Indian Basmati rice have been patented by US Rice-tech Company. "Even India became aware of it after three years," he said and added after a long battle India could patent some of those varieties. Besides ethics, religious and social discrimination and privacy can be issues of concern while using biotech in medical science. Senior Health Secretary Humayun Kabir said there would be regulatory bodies to oversee the activities of medical biotechnology in Bangladesh. bdnews24.com/nih/bd/2143h
Related Stories